In the News
Monofilament test for diagnosing diabetic polyneuropathy has high rate of false negatives
A Norwegian study found that the 5.07/10-g monofilament test was less sensitive in women and in older patients and less specific in patients with neuropathic pain. The study's authors recommended against using the monofilament test to diagnose diabetic polyneuropathy.
Baricitinib may preserve beta-cell function in early stages of type 1 diabetes
An editorial noted that increasing knowledge developed from trials of patients with early type 1 diabetes could eventually enable treatment to prevent clinical disease.
CGM use linked with modest HbA1c decreases in patients with type 2 diabetes
Real-time continuous glucose monitoring (CGM) increased the percent of time in range among patients with type 2 diabetes compared with self-monitoring, and both real-time and flash CGM lowered HbA1c levels, a meta-analysis found.
MKSAP quiz: Screening recommendations
This month's quiz asks readers to choose a screening test for a 46-year-old man with hypertension, hyperlipidemia, obesity, and depression.
Spotlight on glycemia and dementia
One study found reduced rates of dementia in patients with type 2 diabetes who took metformin, while another showed that impaired fasting glucose posed a cognitive risk, and a review compared diabetes drug classes for their effects on dementia risk.
Finerenone works by quickly lowering albuminuria, analysis finds
Reductions in the urine albumin-to-creatinine ratio within four months were responsible for 84% of the treatment effect of finerenone on kidney outcomes and 37% of that on cardiovascular outcomes, according to an industry-funded four-year analysis of trials in patients with chronic kidney disease and type 2 diabetes.
Diabetes more common in low-income middle-aged people, rising among higher-income group
Between 1999 and 2020, rates of diabetes and obesity held steady in lower-income middle-aged adults in the U.S., while these risk factors rose among the higher-income middle-aged, from 7.8% to 14.9% and 33.0% to 44.0%, respectively.
Annals On Call: Type 1 diabetes
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode discussed the age at which U.S. adults with type 1 diabetes are being diagnosed.
CGM software authorized, infusion sets recalled, tirzepatide approved for obesity
The FDA cleared a software system that works with continuous glucose monitors (CGMs) and insulin pumps for marketing and announced the recall of some lots of insulin infusion sets.